Clinical Trial Detail

NCT ID NCT02110082
Title Combination Study of Urelumab and Cetuximab in Patients With Advanced/Metastatic Colorectal Cancer or Advanced/Metastatic Head and Neck Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements no
Sponsors Bristol-Myers Squibb
Indications

colorectal cancer

head and neck squamous cell carcinoma

Therapies

Cetuximab + Urelumab

Age Groups: adult

No variant requirements are available.